Ahold Delhaize agrees to $40 million settlement over inflated prescription price data

Regulation
โดย TheStreet·Read original
Summary · why it matters

Ahold Delhaize USA has agreed to pay $40 million to resolve allegations that it submitted inflated prescription drug pricing data to federal health care programs. The Justice Department alleged that the grocery chain operator, whose supermarket banners include Giant, Hannaford, Stop & Shop, and Food Lion, failed to report discounted prescription prices as its usual and customary rates when billing Medicare Part D, Medicaid, and Tricare, causing the programs to reimburse pharmacies at higher amounts. Of the total settlement, approximately $32.9 million will go to the federal government, with the remainder distributed among participating states, and whistleblower Lawrence LaBenne will receive more than $6 million. Ahold Delhaize emphasized that the settlement resolves allegations without an admission of wrongdoing and noted that the billing questions relate to programs discontinued nearly a decade ago.

Impact on stocks 1

Consumer Staples · 1 stocks
Koninklijke Ahold Delhaize NV
AD
▼ NegativeRegulationrelevance

Settlement of $40 million over inflated prescription pricing data allegations with federal health programs.